There are 2789 resources available
515MO - A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC)
Presenter: Joline Lim
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
516MO - Phase I/II study of eprenetapopt (APR-246) in combination with pembrolizumab in patients with solid tumor malignancies
Presenter: Haeseong Park
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
517MO - Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumours
Presenter: Natalie Cook
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
518MO - Tolerability and preliminary clinical activity of SY-5609, a highly potent and selective oral CDK7 inhibitor, in patients with advanced solid tumors
Presenter: Manish Sharma
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
519MO - Concordance analysis of treatment recommendations between central consensus and multidisciplinary tumor boards
Presenter: Hidenori Kage
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
520MO - Using patient-reported outcomes (PROs) in dose-finding oncology trials (DFOT): Results from a global stakeholder survey and the National Cancer Research Institute (NCRI) Consumer Forum
Presenter: Julia Lai-Kwon
Session: Mini oral session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
343MO - Clinical features and DNA methylation patterns in long- and short-term survivors of WHO grade II-III glioma
Presenter: Maximilian Mair
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
344MO - Experience of GEINO (Spanish cooperative group for research in neuro-oncology) oncologists in the management of adult medulloblastoma
Presenter: Maria Vieito Villar
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
345MO - Treatment associated changes in the inflammatory microenvironment composition of brain metastases
Presenter: Ariane Steindl
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast
346MO - Safety of idroxioleic acid in combination with standard of care (temozolomide and/or radiation therapy) in newly diagnosed glioblastoma patients: A phase Ib trial
Presenter: Carme Balaña
Session: Mini oral session - CNS tumours
Resources:
Abstract
Slides
Webcast